tiprankstipranks
Advertisement
Advertisement

ABEO Stock Latest News

Abeona Therapeutics: CMS Reimbursement Catalyst Supports ZEVASKYN Uptake and Unchanged $20 Price Target
RatingsAbeona Therapeutics: CMS Reimbursement Catalyst Supports ZEVASKYN Uptake and Unchanged $20 Price Target
1d ago
ABEO
Abeona Therapeutics activates Cincinnati Children’s as treatment center
PremiumThe Fly
Abeona Therapeutics activates Cincinnati Children’s as treatment center
16d ago
ABEO
Arqit, American Eagle, Abeona, Vipshop, Verisign Shake-Up
PremiumWeekend Updates
Arqit, American Eagle, Abeona, Vipshop, Verisign Shake-Up
26d ago
AEO
ABEO
uniQure, Protara, Abeona, Cerebras, Verisign Insider Shake-Up
PremiumWeekend Updates
uniQure, Protara, Abeona, Cerebras, Verisign Insider Shake-Up
1M ago
ABEO
CBRS
Abeona Shareholders Back Board, Equity Plan at Meeting
PremiumCompany Announcements
Abeona Shareholders Back Board, Equity Plan at Meeting
2M ago
8K
ABEO
Abeona Therapeutics announces resignation of board member
PremiumCompany AnnouncementsAbeona Therapeutics announces resignation of board member
2M ago
8K
ABEO
Abeona Therapeutics Updates Investor Presentation Under Regulation FD
Premium
Company Announcements
Abeona Therapeutics Updates Investor Presentation Under Regulation FD
2M ago
8K
ABEO
Abeona Advances ABO-701 T-Cell Therapy Toward IND
Premium
Company Announcements
Abeona Advances ABO-701 T-Cell Therapy Toward IND
2M ago
8K
ABEO
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
PremiumCompany Announcements
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum
3M ago
ABEO
Abeona Therapeutics Signals Strong Early ZEVASKYN Launch
PremiumCompany Announcements
Abeona Therapeutics Signals Strong Early ZEVASKYN Launch
3M ago
ABEO
Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)
PremiumThe Fly
Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)
3M ago
ABEO
ABEO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ABEO Upcoming Earnings Report: What to Expect?
3M ago
ABEO
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
PremiumCompany AnnouncementsAbeona Therapeutics Adds Keith Goldan to Board, Audit Chair
4M ago
8K
ABEO
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
Premium
Company Announcements
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
5M ago
8K
ABEO
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
Premium
Ratings
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
5M ago
ABEO
Abeona Therapeutics Balances Big Windfall With Slow Ramp
PremiumCompany Announcements
Abeona Therapeutics Balances Big Windfall With Slow Ramp
5M ago
ABEO
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
PremiumThe Fly
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
5M ago
ABEO
Options Volatility and Implied Earnings Moves Today, March 17, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 17, 2026
5M ago
ASO
TME
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
PremiumThe Fly
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
5M ago
ABEO
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
5M ago
M
MU
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
ABEO
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
Premium
Ratings
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
5M ago
ABEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >